Ironwood Pharmaceuticals (IRWD) EBIT Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | 21.25% |
| 10 | Ironwood Pharmaceuticals | 644.81 Mn | 424.34 Mn | - | 349.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 349.32% |
| Dec 31, 2025 | -78.39% |
| Sep 30, 2025 | 194.45% |
| Jun 30, 2025 | 81.45% |
| Mar 31, 2025 | -364.14% |
| Dec 31, 2024 | -16.22% |
| Sep 30, 2024 | -35.95% |
| Jun 30, 2024 | 102.31% |
| Mar 31, 2024 | -81.66% |
| Dec 31, 2023 | -45.02% |
| Sep 30, 2023 | -41.55% |
| Jun 30, 2023 | -2,046.17% |
| Mar 31, 2023 | 3.89% |
| Dec 31, 2022 | 20.80% |
| Sep 30, 2022 | 5.07% |
| Jun 30, 2022 | -14.51% |
| Mar 31, 2022 | 27.42% |
| Dec 31, 2021 | 10.14% |
| Sep 30, 2021 | 42.87% |
| Jun 30, 2021 | 99.00% |